MedTrace Logo

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk

NCT00874185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 720

Last updated 2021-02-01

No results posted yet for this study

Summary

Evaluate satisfaction in people treated with IPDE5 inhibitors over time

Conditions

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-05-31
Completion
2008-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874185 on ClinicalTrials.gov